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1. Introduction 
Although soft-tissue sarcomas account for <1% of all malignancies, they represent a high 
percentage of cancer-related deaths worldwide [1]. These tumors may arise in virtually any 
anatomic site, but most originate in an extremity (59%), the trunk (19%), the 
retroperitoneum (15%), or the head and neck (9%) [2]. Currently, more than 50 histologic 
types of soft tissue sarcoma have been identified, but the most common are malignant 
fibrous histiocytoma (28%), leiomyosarcoma (12%), liposarcoma (15%), synovial sarcoma 
(10%), and malignant peripheral nerve sheath tumors (6%) [3]. Rhabdomyosarcoma is the 
most common soft tissue sarcoma of childhood. 
2. The role of the pathology 
As part of the evaluation by a specialist multidisciplinary team, accurate histological 
characterisation is essential before initiating treatment. The mainstay of diagnosis is 
histological interpretation±immunohistochemistry, although cytogenetic and molecular 
genetics investigations and, occasionally, electron microscopy are useful ancillary tools. 
Cytological analysis of fine-needle aspirates has a limited role in primary diagnosis, but can 
be used to confirm recurrent disease, or nodal metastases.  
The histopathology report is an interpretation based on tumour morphology and 
immunoprofile in the available sampled tissue, and clinicopathological correlation is 
mandatory. 
Diagnosis is most frequently made on needle core biopsy material, and tumour subtype and 
grade can be determined in about 80% of core biopsies [4], although pathologists 
experienced in examining soft tissue tumours have a diagnostic accuracy of 95-99% [4,5]. 
The amount of tissue can be a limitation, as the biopsy may not represent the entire, 
frequently heterogeneous tumour, or may miss the tumour. For this reason, correlation 
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between the clinicoradiological features and the histopathology report is essential, and 
rebiopsy considered if there is any discrepancy.  
The mitotic count, amount of necrosis and degree of cellular atypia can be underrepresented in 
biopsies, and a significant proportion of tumours are upgraded after subsequent resection. 
The limitations of histology should be appreciated. There is notable morphological overlap 
between different groups of malignant tumours, with different clinical behaviours and 
therapeutic responses.  
Some tumours are resected after neoadjuvant chemotherapy, or post-adjuvant 
chemotherapy or radiation. Post-treatment changes include stromal fibrosis and tumoral 
infarct, the latter difficult to distinguish from necrosis, making grading difficult. Radiation 
can cause reactive atypia of stromal fibroblasts, obscuring distinction between tumour and 
stromal tissue. 
The clinical behavior of most soft tissue sarcomas is similar and, as defined by the 
staging system, is determined by the anatomic location (depth), grade, and size of the 
tumor. The histologic grade of a soft tissue sarcoma remains the most important prognostic 
factor.  
The features that define the grade are the degree of cellularity, differentiation, 
pleomorphism, and necrosis as well as the number of mitoses. Certain tumors have an 
assigned grade based on the histologic diagnosis (eg, Grade 1 for well-differentiated 
liposarcomas; Grade 3 for rhabdomyosarcoma). 
3. Metastasis of sarcomas 
The current American Joint Committee on Cancer (AJCC) staging criteria for soft tissue 
sarcomas rely on the histologic grade, the tumor size and depth, and the presence of distant 
or nodal metastases [6]. In the 2002 AJCC staging system, four tumor grades are designated: 
well differentiated (G1), moderately differentiated (G2), poorly differentiated (G3), and 
undifferentiated (G4). In this four-tiered system, Grades 1 and 2 are considered low grade 
and Grades 3 and 4 are considered high grade [6]. Some recommend using other grading 
systems based on necrosis [7]or mitoses and necrosis [8]. 
The metastatic potentials for soft tissue sarcomas by grade are as follows: 5% to 10% for low-
grade lesions, 25% to 30% for intermediate grade lesions, and 50% to 60% for high-grade 
tumors [9]. 
 Superficial sarcomas are generally less aggressive than their deeper counterparts; for 
example, atypical fatty tumours in the subcutis do not metastasise or dedifferentiate and 
rarely recur, unlike similar intramuscular or retroperitoneal tumours [10].  
The dominant pattern of metastasis is hematogenous. Lymph node metastasis of soft tissue 
sarcomas is rare; less than 5% show nodal spread. A few histologic subtypes, including 
rhabdomyosarcoma, epithelioid sarcoma, synovial sarcoma, angiosarcoma, clear cell 
sarcoma, and malignant fibrous histiocytoma, show a higher incidence of nodal 
involvement (10% to 20%) [11]. Alveolar rhabdomyosarcoma can present with widespread 
nodal as well as bone marrow metastases. Myxoid liposarcoma is known for metastasizing 
to other soft tissue sites [10]. 
Distant metastases occur most often to the lung. Of patients with extremity sarcoma, 
approximately 20% will have isolated pulmonary metastatic disease at some point in the 
course of their disease [12]. Although pulmonary metastases most commonly arise from 
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Fig. 1. Abdominal magnetic resonance imaging showing a 5-cm hepatic mass of segment V [26]. 
 
 
Fig. 2. Operative view showing a large firm mass in segments V and VI of the liver [26]. 
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Fig. 3. Section in the mass in segments V and VI [26]. 
primary tumors in the extremities, they may arise from almost any histologic variant or 
primary site [13]. Extrapulmonary metastases usually appear after lung metastasis and 
represent disseminated disease [14]. Initial metastases to other sites such as the liver, brain, 
and soft tissue distant from the primary tumor are rare [15, 16]. In our study, we report one 
case of liver metastases of  malignant fibrous histiocytoma[fig 1-4]. Pezzi et al. reported that 
most metastases of MFH occurred in the lungs (90%), followed by bone (8%). However, liver 
metastases of this tumour are very rare (1%) [24] [26]. 
Liposarcoma has a documented tendency for spread to distant extrapulmonary sites other 
than regional lymph nodes [17, 18, 19]. Cheng et al [17] reported on 60 patients with 
extremity liposarcoma, of which 22 developed metastases. Of these 22 liposarcoma patients, 
13 had exclusively extrapulmonary disease on recurrence. 
Distant soft tissue was the most common location of unusual initial spread reported by 
Cheng et al, including the brain and abdomen [17]. Many investigators have noted an 
increased prevalence of myxoid liposarcoma to exhibit unusual metastases compared to 
other subtypes of liposarcoma [19]. 
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Fig. 4. Histological examination showing spindle-shaped and pleomorphic malignant cells 
intermingled with bizarre giant cells and inflammatory cells with a storiform pattern [26]. 
Other large series including all histologic types of high-grade sarcoma have reported 
unusual metastatic patterns. Potter et al found 15 distant extrapulmonary metastases in their 
series of 563 patients (2.7%) [20]. Vezeridis et al [21] also documented extrapulmonary 
distant metastases, but both of these studies were failing to demonstrate a consistent pattern 
in terms of anatomic location of the initial unusual metastatic site.  
In our experience, over a period of 10 years (1998-2007), 13,737 cases of cancer are registered 
in the central region of Tunisia. 357 (2.6%) cases are soft tissue sarcomas, and 40 (11.2%) of 
them were diagnosed with metastatic disease. 
Histological types who give most metastases are synovial sarcoma, stromal tumor and 
undifferentiated sarcoma (Table No. I). The lung was the most common site of metastatic 
sarcomas. 
Postulating that soft-tissue sarcomas metastasize via the venous system may account for the 
predominance of distant recurrence in the lungs. The mechanism of extrapulmonary 
metastasis is less clear. In 1946, Tedeschi [22] proposed the concept of pluricentric anlage, 
referring to systemically altered lipid metabolism causing stimulation of undifferentiated 
mesenchymal cells to explain patients he observed with fatty tumors in multiple soft-tissue 
locations. While this concept has been used to explain the development of multiple 
subcutaneous nodules in patients with neurofibromatosis, it seems to be a less robust 
explanation for the usual clinical course of sarcoma [23]. The mechanism of unusual distant 
metastasis remains obscure.  
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Fig. 5. Abdominal CT scan showing multiple cystic metastasis of a GIST with intracystic 
enhancing nodules 
 
Histologic type All of cases Sarcomas Stage IV Metastatic site 
Undifferentiated sarcoma 82 11 (13,41%) 
Lung (6), liver (5), 
bone (1), lymph 
node (1) 
stromal tumor (GIST) 33 7 (21.21%) 
liver (6), peritonium 
(1) 
Synovialosarcoma 21 6 (28.57%) Lung (6), bone (2) 
Leiomyosarcoma 26 5 (19.23%) 
Lung (6), bone (2), 
lymph node (1) 
Ewing sarcoma 7 3 (42.85%) Lung (3), brain (1) 
Rhabdomyosarcoma 23 3 (13%) 
Lung (1), 
peritonium (2) 
Malignant fibrous 
histiocytoma 
25 2 (8%) 
peritonium (1), 
lymph node (1) 
Desmoplastic Intrabdominal 
round cell tumor 
8 2 (25%) 
Rectum (1), bladder 
(1) 
Fibrosarcoma 14 1 (7.14%) Liver (1) 
Other sarcomas  118 0  
Total 357 40 (11.2%)  
Table 1. Histological type of sarcoma stage IV and metastatic sites  
(1998-2007: The Central  region of Tunisia)  
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Liver metastasis of GIST are frequent. It mainly occurs after incomplete resection of the 
primitive lesion. Surgical resection is the preferred treatment, but there is a high rate of 
recurrence. Imatinib is the treatment of choice for these cases. With effective treatment, GIST 
becomes entirely cystic. Upon reactivation, the cysts develop intracystic enhancing nodules 
[25] 
We report a case of liver metastasis of GIST that occurred three years after the incomplete 
resection of the intestinal tumor treated with Imatinib. The CT scan showed the 
development of intracystic enhancing nodules within Six months of Imatinib.  
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